Jennifer Bullen

Jennifer Bullen

Auto-generated profile, based on publicly available information

Jennifer Bullen

Cleveland Clinic, Cleveland, USA

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2022 in Radiology
Verified
Journal Article
Closed access
NONancy A. Obuchowski
Nancy A. Obuchowski
JBJennifer Bullen
Jennifer Bullen
The multireader multicase (MRMC) design is a commonly used tool in diagnostic imaging, yet if poorly designed or misanalyzed, MRMC studies can provide misleading results and waste valuable resources. The design and analysis of multireader multicase (MRMC) studies are quite challenging. These studies differ from most medical studies because they need a reference standard and sampling from two po...

1 January 2020 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
UHUrsula Heilmeier
Ursula Heilmeier
KMK. Mamoto
K. Mamoto
KAK. Amano
K. Amano
BEBrendan Lee Eck
Brendan Lee Eck
MTM. Tanaka
M. Tanaka
XLX. Li
X. Li

1 April 2016 in Academic Radiology
Verified
Journal Article
Closed access
NONancy A. Obuchowski
Nancy A. Obuchowski
ABAndrew Buckler
Andrew Buckler
PKPaul E Kinahan
Paul E Kinahan
HCHeather Chen-Mayer
Heather Chen-Mayer
NPNicholas Petrick
Nicholas Petrick
DSDaniel C. Sullivan
Daniel C. Sullivan

27 February 2017 in Statistical Methods in Medical Research
Verified
Journal Article
Closed access
NONancy A Obuchowski
Nancy A Obuchowski
JBJennifer Bullen
Jennifer Bullen
Introduction: Quantitative imaging biomarkers (QIBs) are being increasingly used in medical practice and clinical trials. An essential first step in the adoption of a quantitative imaging biomarker is the characterization of its technical performance, i.e. precision and bias, through one or more performance studies. Then, given the technical performance, a confidence interval for a new patient’s true biomarker value can be constructed. Estimating bias and precision can be problematic because rarely are both estimated in the same study, precision studies are usually quite small, and bias cannot be measured when there is no reference standard. Methods: A Monte Carlo simulation study was conducted to assess factors affecting nominal coverage of confidence intervals for a new patient’s quantitative imaging biomarker measurement and for change in the quantitative imaging biomarker over time. Factors considered include sample size for estimating bias and precision, effect of fixed and non-proportional bias, clustered data, and absence of a reference standard. Results: Technical performance studies of a quantitative imaging biomarker should include at least 35 test–retest subjects to estimate precision and 65 cases to estimate bias. Confidence intervals for a new patient’s quantitative imaging biomarker measurement constructed under the no-bias assumption provide nominal coverage as long as the fixed bias is <12%. For confidence intervals of the true change over time, linearity must hold and the slope of the regression of the measurements vs. true values should be between 0.95 and 1.05. The regression slope can be assessed adequately as long as fixed multiples of the measurand can be generated. Even small non-proportional bias greatly reduces confidence interval coverage. Multiple lesions in the same subject can be treated as independent when estimating precision. Conclusion: Technical performance studies of quantitative imaging biomarkers require moderate sample sizes in order to provide robust estimates of bias and precision for constructing confidence intervals for new patients. Assumptions of linearity and non-proportional bias should be assessed thoroughly.

9 September 2019 in Neurosurgery
Verified
Journal Article
Closed access
GTGabor Toth
Gabor Toth
SOSantiago Ortega-Gutierrez
Santiago Ortega-Gutierrez
JTJenny P Tsai
Jenny P Tsai
RCRussell Cerejo
Russell Cerejo
SKSami Al Kasab
Sami Al Kasab
ESEdgar A Samaniego
Edgar A Samaniego
BACKGROUND: Prospective evidence to support mechanical thrombectomy (MT) for mild ischemic stroke with large vessel occlusion (LVO) is lacking. There is uncertainty about using an invasive procedure in patients with mild symptoms. OBJECTIVE: To evaluate the safety and feasibility of MT in patients with mild symptoms and LVO. METHODS: Our single-arm prospective pilot study recruited patients with LVO and initial National Institute of Health Stroke Scale (NIHSS) <6, who underwent standard MT. Primary safety endpoints were symptomatic intracerebral hemorrhage (sICH), and/or worsening NIHSS by ≥4 points. Secondary endpoints included angiographic recanalization, NIHSS change, final infarct volume, and modified Rankin score (mRS). RESULTS: We enrolled 20 patients (mean age 65.6 ± 12.3 yr; 45% females). Thrombolysis in Cerebral Ischemia 2B/3 thrombectomy was achieved in 95%. No patients suffered sICH. One patient (5%) had neurologic worsening within 24 h because of underlying intracranial stenosis. No other complications or safety concerns were identified. Median NIHSS was significantly better at discharge (0.5, P = .007) and at last follow-up (0, P < .001) than before treatment (3). Mean post vs preintervention infarct volumes were small without significant difference (1.2 ml, P = .434). Most patients (85%) were discharged directly home. Excellent clinical outcome (mRS 0-1) at last follow-up was seen in 95% of patients. CONCLUSION: This is one of the first specifically designed prospective studies showing that MT is safe and feasible in patients with low NIHSS and LVO. Chronic underlying vasculopathy may be a challenging dilemma. We observed excellent clinical and radiographic outcomes, but randomized controlled trials are needed to demonstrate the efficacy of MT in this unique cohort.

1 April 2023 in Journal of Urology
Verified
Journal Article
Closed access
TBTarik Benidir
Tarik Benidir
EAEthan Austhof
Ethan Austhof
RWRyan D. Ward
Ryan D. Ward
JRJustin Ream
Justin Ream
JBJenifer Bullen
Jenifer Bullen
APAndrei S. Purysko
Andrei S. Purysko
Introduction:Prostatic urethral lift with UroLift® is a minimally invasive approach to treat symptomatic benign prostatic hypertrophy. This device causes artifacts on prostate MR images. Ou...